GRANT score: A new tool to predict survival in kidney cancer patients

A recent study, published in Scientific Reports last month, describes the validation of a new scoring system for renal cell carcinoma (RCC) called GRade, Age, Nodes and Tumour (GRANT). GRANT can be used to predict survival of RCC patients who have had a nephrectomy. In this study, GRANT was validated in over 73,000 kidney cancer […]

read more

Developments in data for rare and less common cancers

Cancer52 and the National Cancer Registration and Analysis Service (NCRAS) at Public Health England (PHE) are delighted to be able to share a film and a report of the very successful Developments in Data for Rare and Less Common Cancers event held on 22nd May 2019. The report provides a written overview of the whole event and the film includes snippets […]

read more

Data-driven approach to personalised care

One of the greatest strengths of the NHS is its comprehensive datasets of the population from birth to death. A recent paper proposes a new model of cancer care and looks at how data could be examined and used at every stage of the treatment journey, from prevention and diagnosis through to treatment and recovery. […]

read more

NICE exploring ways to use real world data

The National Institute of Health and Care Excellence (NICE) is planning to extend its use of real world data to help inform its independent committees who produce its guidance. NICE already makes use of a wide range of published scientific evidence for its guidance for the NHS on health technologies for a range of medical […]

read more

Clinical characteristics and genomic alterations associated with outcome in chromophobe RCC

A recent study by researchers in New York, USA, and published in Clinical Genitourinary Cancer identified gene alterations and clinical characteristics that could help predict outcome in patients with a rare form of renal cell carcinoma (RCC) called chromophobe RCC. These gene alterations and clinical characteristics could also help identify potential targeted therapy options in […]

read more

Advanced Kidney Cancer Centre of Excellence

The Advanced Kidney Cancer Center of Excellence from UroToday and GU OncToday delivers disease, treatment and guidelines information in this rapidly changing area. This series of articles explores ongoing clinical trials, including trials looking at biomarkers and genomic data, in addition to live conference coverage that will provide real-time perspectives from Dr Sumanta Kumar Pal and […]

read more

Patients are willing to share personal data with the NHS, but not pharma

This blog starts with the results of a survey of 2000 people, 56% of which said they would be happy to share personal data with the NHS if it led to better services. But only 15% of those surveyed said they would be prepared to share personal data with pharmaceutical companies. The blog goes on to […]

read more

UK patient groups say that pharma could be more transparent

An independent study of the views of 83 UK-based patient groups on the corporate reputation of 15 pharmaceutical companies, and of the pharma industry as a whole, reported a lack of transparency at sharing clinical data. The study was conducted by PatientView, and collected the opinions of patient groups in a survey conducted between November […]

read more
Showing all 8 results
  TOP